IGM Retained Earnings from 2010 to 2024

IGMS Stock

USD 8.89 0.88 9.01%

IGM Biosciences Retained Earnings yearly trend continues to be comparatively stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that IGM Biosciences retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2018-03-31

Previous Quarter

-919 M

Current Value

-980.4 M

Quarterly Volatility

308.8 M

Covid

Check IGM Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IGM Biosciences' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 8.7 M or Interest Expense of 8.3 M, as well as many indicators such as Price To Sales Ratio of 194, Dividend Yield of 0.0 or PTB Ratio of 2.25. IGM financial statements analysis is a perfect complement when working with IGM Biosciences Valuation or Volatility modules.

Check out the analysis of IGM Biosciences Correlation against competitors.

For more information on how to buy IGM Stock please use our How to Invest in IGM Biosciences guide.

Latest IGM Biosciences' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of IGM Biosciences over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. IGM Biosciences' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IGM Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (821.24 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

IGM Retained Earnings Regression Statistics

	Arithmetic Mean	(214,713,127)
	Coefficient Of Variation	(131.26)
	Mean Deviation	222,815,919
	Median	(41,361,000)
	Standard Deviation	281,827,919
	Sample Variance	79427T
	Range	779.9M
	R-Value	(0.81)
	Mean Square Error	28855.8T
	R-Squared	0.66
	Significance	0.0002
	Slope	(51,299,255)
	Total Sum of Squares	1111977.7T

IGM Retained Earnings History

	2024	-780.2 M
	2023	-821.2 M
	2022	-574.8 M
	2021	-353.7 M
	2020	-188.6 M
	2019	-107.2 M
	2018	-64.1 M

Other Fundumenentals of IGM Biosciences

Retained Earnings Total Equity

IGM Biosciences Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Receivables	Capital Stock
Total Assets		-0.34	0.97	-0.79	-0.8	0.7	0.95	0.65	0.95	1.0	1.0	0.98	0.87	0.71	0.89	0.96
Total Stockholder Equity	-0.34		-0.27	0.3	-0.09	-0.46	-0.15	0.07	-0.37	-0.35	-0.35	-0.38	0.02	-0.74	-0.14	-0.13
Net Tangible Assets	0.97	-0.27		-0.85	-0.72	0.8	0.94	0.5	0.98	0.97	0.98	0.97	0.79	0.75	0.86	0.94
Net Debt	-0.79	0.3	-0.85		0.48	-0.92	-0.77	-0.25	-0.87	-0.8	-0.82	-0.75	-0.57	-0.67	-0.8	-0.68
Retained Earnings	-0.8	-0.09	-0.72	0.48		-0.25	-0.89	-0.93	-0.64	-0.78	-0.76	-0.76	-0.98	-0.2	-0.9	-0.88
Accounts Payable	0.7	-0.46	0.8	-0.92	-0.25		0.66	-0.02	0.86	0.72	0.74	0.72	0.35	0.86	0.62	0.58
Capital Surpluse	0.95	-0.15	0.94	-0.77	-0.89	0.66		0.7	0.91	0.94	0.93	0.94	0.92	0.59	0.96	0.96
Total Liab	0.65	0.07	0.5	-0.25	-0.93	-0.02	0.7		0.43	0.63	0.61	0.59	0.91	0.02	0.74	0.71
Net Invested Capital	0.95	-0.37	0.98	-0.87	-0.64	0.86	0.91	0.43		0.96	0.97	0.96	0.74	0.83	0.83	0.89
Total Current Assets	1.0	-0.35	0.97	-0.8	-0.78	0.72	0.94	0.63	0.96		1.0	0.98	0.86	0.73	0.88	0.95
Net Working Capital	1.0	-0.35	0.98	-0.82	-0.76	0.74	0.93	0.61	0.97	1.0		0.98	0.84	0.74	0.87	0.94
Common Stock	0.98	-0.38	0.97	-0.75	-0.76	0.72	0.94	0.59	0.96	0.98	0.98		0.83	0.78	0.86	0.95
Property Plant Equipment	0.87	0.02	0.79	-0.57	-0.98	0.35	0.92	0.91	0.74	0.86	0.84	0.83		0.31	0.91	0.91
Current Deferred Revenue	0.71	-0.74	0.75	-0.67	-0.2	0.86	0.59	0.02	0.83	0.73	0.74	0.78	0.31		0.46	0.57
Net Receivables	0.89	-0.14	0.86	-0.8	-0.9	0.62	0.96	0.74	0.83	0.88	0.87	0.86	0.91	0.46		0.89
Capital Stock	0.96	-0.13	0.94	-0.68	-0.88	0.58	0.96	0.71	0.89	0.95	0.94	0.95	0.91	0.57	0.89

Click cells to compare fundamentals

About IGM Biosciences Financial Statements

IGM Biosciences shareholders use historical fundamental indicators, such as Retained Earnings, to determine how well the company is positioned to perform in the future. Although IGM Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in IGM Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on IGM Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Retained Earnings	-821.2 M	-780.2 M
Retained Earnings Total Equity	-318.4 M	-302.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for IGM Stock Analysis

When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC